Actuate Therapeutics, Inc. announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for elraglusib...
Read moreFoldax announced that the first 30 patients have been treated outside of the U.S., in the Indian clinical trial...
Read moreIn recent years, the global community has been increasingly concerned about the detrimental impacts of conventional pest control methods...
Read moreKairos Ventures is pleased to announce that Northwestern University Professor Mercouri Kanatzidis, the founder of our portfolio company Actinia, Inc., has received another...
Read moreNorthwestern University Professor Mercouri Kanatzidis, who was elected to the American Academy of Arts & Sciences earlier this year,...
Read moreMemVerge unveiled Memory Machine Cloud Essentials, Pro, and Enterprise built on the company's innovative Cloud Automation 2.0 technology.
Read moreAmorphology is the first company to develop the commercialization of bulk metallic glass flexsplines for strain wave gears, planetary...
Read moreAxial Therapeutics announced it has received a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF)...
Read moreAptamer Group plc, the developer of novel Optimer® binders to enable innovation in the life sciences industry, and Neuro-Bio,...
Read moreSpecter Aerospace announced that it had secured over $9.5 million in previously undisclosed venture and government funding today. ...
Read more